What to read around the web today
- Chinese biotech startup Harbour BioMed secures $102.8M in Series C round (China Money Network)
- Methotrexate-loaded tumour-cell-derived microvesicles can relieve biliary obstruction in patients with extrahepatic cholangiocarcinoma (Nature Biomedical Engineering)
- Ophthalmic drugs, cancer cell therapies attract $340M+ on two HKEX biotech debuts (Endpoints News)
- China's Sinovac Phase III trials in Brazil could take as little as three months (BioWorld)
No hay comentarios:
Publicar un comentario